Echo Therapeutics Inc. (ECTE) Financials Nov 14, 2014, 3:27 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Echo Therapeutics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.33M 428,460 447,211 5,119 27,600
Cost of Goods Sold (COGS) incl. D&A 158,618 109,413 - - -
COGS excluding D&A 0 0 - - -
Depreciation & Amortization Expense 158,618 109,413 47,916 145,155 391,595
Depreciation 40,618 25,413 47,916 - -
Amortization of Intangibles 118,000 84,000 0 - -
Gross Income 1.17M 319,047 - - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.7M 5.23M 8.65M 14.9M 19.27M
Research & Development 2.69M 2.58M 3.8M 8.67M 11.3M
Other SG&A 3.01M 2.65M 4.86M 6.23M 7.97M
Other Operating Expense 0 0 0 0 0
Unusual Expense 6.1M (555,208) 1.76M (3.68M) (4.47M)
EBIT after Unusual Expense (6.1M) 555,208 (1.76M) 3.68M 4.47M
Non Operating Income/Expense 0 244,480 (1,348) (21,272) 0
Non-Operating Interest Income 1,562 1,519 4,808 5,466 3,052
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 331,500 37,549 13,926 959,858 3.9M
Gross Interest Expense 331,500 37,549 13,926 959,858 3.9M
Interest Capitalized 0 0 0 0 0
Pretax Income (10.96M) (4.15M) (10.03M) (12.33M) (19.07M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (10.96M) (4.15M) (10.03M) (12.33M) (19.07M)
Minority Interest Expense 0 0 0 0 0
Net Income (10.96M) (4.15M) (10.03M) (12.33M) (19.07M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (10.96M) (4.15M) (10.03M) (12.33M) (19.07M)
Preferred Dividends 2.55M 131,659 6.69M 0 371,140
Net Income Available to Common (13.51M) (4.28M) (16.72M) (12.33M) (19.44M)
EPS (Basic) (6.10) (1.50) (4.90) (3.10) (2.33)
Basic Shares Outstanding 2.23M 2.9M 3.42M 3.96M 8.36M
EPS (Diluted) (6.10) (1.50) (4.90) (3.10) (2.33)
Diluted Shares Outstanding 2.23M 2.9M 3.42M 3.96M 8.36M
EBITDA (4.37M) (4.8M) (8.21M) (14.89M) (19.24M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Echo Therapeutics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.33M 428,460 447,211 5,119 27,600
Cost of Goods Sold (COGS) incl. D&A 158,618 109,413 - - -
COGS excluding D&A 0 0 - - -
Depreciation & Amortization Expense 158,618 109,413 47,916 145,155 391,595
Depreciation 40,618 25,413 47,916 - -
Amortization of Intangibles 118,000 84,000 0 - -
Gross Income 1.17M 319,047 - - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.7M 5.23M 8.65M 14.9M 19.27M
Research & Development 2.69M 2.58M 3.8M 8.67M 11.3M
Other SG&A 3.01M 2.65M 4.86M 6.23M 7.97M
Other Operating Expense 0 0 0 0 0
Unusual Expense 6.1M (555,208) 1.76M (3.68M) (4.47M)
EBIT after Unusual Expense (6.1M) 555,208 (1.76M) 3.68M 4.47M
Non Operating Income/Expense 0 244,480 (1,348) (21,272) 0
Non-Operating Interest Income 1,562 1,519 4,808 5,466 3,052
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 331,500 37,549 13,926 959,858 3.9M
Gross Interest Expense 331,500 37,549 13,926 959,858 3.9M
Interest Capitalized 0 0 0 0 0
Pretax Income (10.96M) (4.15M) (10.03M) (12.33M) (19.07M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (10.96M) (4.15M) (10.03M) (12.33M) (19.07M)
Minority Interest Expense 0 0 0 0 0
Net Income (10.96M) (4.15M) (10.03M) (12.33M) (19.07M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (10.96M) (4.15M) (10.03M) (12.33M) (19.07M)
Preferred Dividends 2.55M 131,659 6.69M 0 371,140
Net Income Available to Common (13.51M) (4.28M) (16.72M) (12.33M) (19.44M)
EPS (Basic) (6.10) (1.50) (4.90) (3.10) (2.33)
Basic Shares Outstanding 2.23M 2.9M 3.42M 3.96M 8.36M
EPS (Diluted) (6.10) (1.50) (4.90) (3.10) (2.33)
Diluted Shares Outstanding 2.23M 2.9M 3.42M 3.96M 8.36M
EBITDA (4.37M) (4.8M) (8.21M) (14.89M) (19.24M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
